Alzheimer's disease and women;Enfermedad de Alzheimer y mujer

Revista de Neurologia

Volumn 35, Issue 6, 2002, Pages 571-579

  Alberca, R ^a   Montes Latorre, Enrique ^a   Gil Neciga E ^a   Mir Rivera, P ^a   Lozano San Martin P ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Alzheimer; Dementia; Education; Estrogens; Female

Indexed keywords

ESTROGEN;

AGE; ALZHEIMER DISEASE; CAREGIVER; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ECONOMIC ASPECT; EDUCATION; ENVIRONMENTAL FACTOR; HEREDITY; HORMONE SUBSTITUTION; HUMAN; LIFESPAN; MENOPAUSE; PATHOGENESIS; PATIENT CARE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SOCIAL ASPECT; SOCIOECONOMICS;

EID: 0037120647     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3506.2001530     Document Type: Review

References (108)

1. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987; 76: 465-79.
2. Hy LX, Keller DM. Prevalence of AD among whites: a summary by levels of severity. Neurology 2000; 55: 198-204.
3. Prencipe M, Casini AR, Ferretti C, Lattanzio MT, Fiorelli M, Culasso F. Prevalence of dementia in an elderly rural population: effects of age, sex, and education. J Neurol Neurosurg Psychiatry 1996; 60: 628-33.
4. Chandra V, Ganguli M, Panday R, Johnston J, Belle S, de Kosky ST. Prevalence of Alzheimer's disease and other dementias in rural India. The Indo-Us study. Neurology 1998; 51: 1000-8.
5. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol 2001; 153: 132-6.
6. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54 (Suppl 5): S4-9.
7. Bermejo F. La carga de la enfermedad de Alzheimer. Continua Neurológica 1998; 1: 3-16.
8. van Duijn CM. Epidemiology of the dementias: recent development and new approaches. J Neurol Neurosurg Psychiatry 1996; 60: 478-88.
9. Evans DA, Ganguli M, Harris T, Kawas C, Larson EB. Women and Alzheimer's disease. Alz Dis Assoc Disord 1999; 13: 187-9.
10. Brayne C, Gill C, Barkley C, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge project for later life. Br J Psychiatry 1995; 167: 255-62.
11. Jorm AF, Jolley D. The incidence of dementia. A meta-analysis. Neurology 1998; 51: 728-33.
12. Ott A, van Rossum CT, van Harskamp F, van de Mheen H, Hofman A, Breteler MM. Education and the incidence of dementia in a large population-based study: the Rotterdam study. Neurology 1999; 52: 663-6.
13. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 1999; 52: 78-84.
14. Copeland JR, McCracken CF, Dewey ME, et al. Undifferentiated dementia, Alzheimer's disease and vascular dementia: age- and gender-related incidence in Liverpool. The MRC-ALPHA study. Br J Psychiatry 1999; 175: 433-8.
15. Fratiglioni L, Viitanen M, von Straus E, Tontodonati V, Herlitz A, Winbland B. Very old woman at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholm project, Stockolm. Neurology 1997; 48: 132-8.
16. Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54 (Suppl 5): S34-7.
17. The Canadian Study of Health and Aging Working Group. The incidence of dementia in Canada. Neurology 2000; 55: 66-73.
18. Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia. The EURODEM studies. Neurology 1999; 53: 1992-7.
19. Letenneur J, Gilleron V, Commenges D, Helmer C, Rogogozo JM, Dartigues JF. Are sex and education level independent predictors of dementia and Alzheimer's disease? Incident data from the PAQUID project. J Neurol Neurosurg Psychiatry 1999; 66: 177-83.
20. Ganguli M, Dodge HH, Chen P, Belle S, De Kosky ST. The year incidence of dementia in a rural elderly community population. The movies project. Neurology 2000; 54: 1109-16.
21. Gao S, Hendrie HC, Hall KKS, Hui S. The relationship between age, sex, and the incidence of dementia and Alzheimer disease. A meta-analysis. Arch Gen Psychiatry 1998; 55: 809-15.
22. Estadísticas demográficas. Proyección de la población de Andalucía 1991-2006. Sevilla: Instituto de Estadística de Andalucía; 1995.
23. van Dijk PT, Dippel DW, Habbema JD. Survival of patients with dementia. J Am Geriatr Soc 1991; 39: 603-10.
24. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001; 344: 1111-6.
25. Gambasi G, Laplane KL, Landi F. Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Neurology 1999; 53: 508-16.
26. Melton L. Sex is all in the brain: report of a Novartis foundation symposium on the neuronal and cognitive effects of oestrogen. London. UK 7-9 September. Trends Endocrinol Metabol 2000; 11: 69-71.
27. Dubal DB, Wilson ME, Wise PM. Estradiol: a protective and trophic factor in the brain. Alzh Dis Rev 1999; 4: 1-9.
28. Henderson VW. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am J Med 1997; 103: S11-8.
29. Kawas C, Resnick S, Morris A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 1997; 48: 1517-21.
30. Moosman B, Behl CC. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A 1999; 96: 8867-72.
31. Petanceska SS, Nagy V, Frail D, Gandy S. Ovariectomy and 17β-estradiol modulated the levels of Alzheimer's amyloid β peptides in brain. Neurology 2000; 54: 2212-7.
32. Harwood DG, Barker WW, Loewenstein DA, Owny RL, George-Hyslop PS, Mullan M, et al. A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics. Neurology 1999; 52: 551-6.
33. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429-32.
34. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996; 156: 2213-7.
35. Baldereschi M, Di Carlo A, Lepore V, et al. Estrogen-replacement therapy and Alzheimer's disease in the italian longitudinal study on aging. Neurology 1998; 50: 996-1002.
36. Waring SC, Rocca WA, Petersen RC, O'Brien PC, Tangalos EG, Kokmen E. Postmenopausal estrogen replacement therapy and risk of AD. A population-based study. Neurology 1999; 52: 965-70.
37. Slooter AJ, Bronzova J, Witteman JC, van Broeckhoven C, Hofman A, van Duijn CM. Estrogen use and early onset Alzheimer's disease: a population based study. J Neurol Neurosurg Psychiatry 1999; 67: 779-81.
38. Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogen use, APOE, and cognitive decline. Evidence of gene-environment interaction. Neurology 2000; 54: 1949-53.
39. Henderson VW. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997; 48: S27-35.
40. Mulnard RA, Cotman CW, Kawas C, et al. Replacement therapy for treatment of mild to moderate Alzheimer's disease: a randomized controlled trial. Alzheimer's disease cooperative study. JAMA 2000; 283: 1007-15.
41. Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in women. Randomized, double-blind, placebo-controlled trial. Neurology 2000; 54: 295-301.
42. Asthana S, Baker LD, Craft S, Stanczyck FZ, Veith RC, Raskind MA, et al. High-dose estradiol improves cognition for women with AD. Results of a randomized study. Neurology 2001; 57: 605-12.
43. Cherrier MM, Asthana S, Plymate S, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 2001; 57: 80-8.
44. Lai F, Kamman E, Rebeck GW, Anderson A, Chen Y, Nixon RA. APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome. Neurology 1999; 53: 331-6.
45. Hyman BT, Gomez-Isla T, Briggs M, et al. Apolipoprotein E and cognitive changes in an elderly population. Ann Neurol 1996; 40: 55-66.
46. Post S, Whitehouse PJ. Genetic testing for Alzheimer's disease: ethical and clinical issues. Baltimore: John Hopkins Press; 1990.
47. Mortensen EL, Hogh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 2001; 57: 89-95.
48. Brestky PM, Buckwalter JG, Seeman TE, et al. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzh Dis Assoc Disord 1999; 13: 216-21.
49. Combarros O, Leno O, Oterino A, et al. Gender effect on apolipoprotein E e4 allele-associated risk for sporadic Alzheimer's disease. Acta Neurol Scand 1998; 97: 68-71.
50. Ghebremedhin E, Schultz C, Thal DR, Rüb U, Ohm TG, Braak E, et al. Gender and age modify the association between APOE and AD-related neuropathology. Neurology 2001; 56: 1696-701.
51. Craft S, Astahana S, Schellenberg G, et al. Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology 1999; 70: 146-52.
52. Crawford F, Abdullah L, Schinka J, Suo Z, Gold M, Duara R, et al. Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci Lett 2000; 280: 215-9.
53. Schmand B, Lindeboom J, Hooijer C, Jonker C. Relation between education and dementia: the role of test bias revisited. J Neurol Neurosurg Psychiatry 1995; 59: 170-4.
54. Muñoz DG, Ganapathy GR, Eliasziw M, Hachinski V. Educational attainement and socioeconomic status of patients with autopsy-confirmed Alzheimer disease. Arch Neurol 2000; 57: 85-9.
55. Callaham CM, Hall KS, Hui SL, Musick S, Unverzagt FW, Hendrie HC. Relationship of age, education, and occupation with dementia among a community-based sample of African Americans. Arch Neurol 1996; 53: 134-40.
56. The Canadian Study of Health and aging: risk factors for Alzheimer's disease in Canada. Neurology 1994; 44: 2073-80.
57. Chandra V, Philipose V, Bell PA, Lazaroff A, Schoenberg BS. Casecontrol study of late onset 'probable Alzheimer's disease'. Neurology 1987; 37: 1295-300.
58. Dartigues JF, Gagnon M, Mazaux JM, et al. Occupation of life and memory performance in non-demented French elderly community residents. Neurology 1992; 42: 1701-97.
59. Evans DA, Hebert LE, Beckett LA, et al. Education and other measures of socioeconomic status and risk of incidence Alzheimer's disease in a defined population of older persons. Arch Neurol 1997; 54: 1399-405.
60. Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. Br Med J 1995; 310: 970-3.
61. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994; 271: 1004-10.
62. Zhang M, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease in Shangai, China: impact of age, gender and education. Ann Neurol 1990; 27: 428-37.
63. Beard CM, Kokmen E, Offord KP, Kurland LT. Lack of association between Alzheimer's disease and education, occupation, marital status or living arrangement. Neurology 1992; 42: 2063-8.
64. Bickel H, Cooper B. Incidence of relative risk of dementia in an urban elderly population: findings of a prospective field study. Psychol Med 1994; 24: 179-92.
65. Bonauto S, Rocca WA, Lippi A, et al. Education and occupation as risk factors for dementia: a population-based case-control study. Neuroepidemiology 1995; 14: 101-9.
66. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB. The effect of education and the incidence of dementia and Alzheimer's disease in the Framingham study. Neurology 1995; 45: 1707-12.
67. Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991; 41: 1886-92.
68. Fratiglioni L, Ahlbom A, Vitanen M, Winbland V. Risk factors for late-onset Alzheimer's disease: a population-based case-control study. Ann Neurol 1993; 33: 258-66.
69. O'Connor DW, Pollit PA, Treasure FP. The influence of education and social class on the diagnosis of dementia in a community population. Psychol Med 1991; 21: 219-24.
70. Paykel ES, Brayne C, Huppert FA, et al. Incidence of dementia in a population older than 75 years in the United Kingdom. Arch Gen Psychiatry 1994; 51: 325-32.
71. Prince M, Cullen M, Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC Elderly Hypertension Trial. Neurology 1994; 44: 97-104.
72. French JR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B. A case-control study of dementia of the Alzheimer type. Am J Epidemiol 1985; 121: 414-21.
73. Folstein MF, Bassett SS, Anthony JC, Romanoski AJ, Nestadt GR. Dementia case ascertainment in a community survey. J Gerontol 1991; 46: M132-8.
74. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Signon AH, Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984; 15: 335-41.
75. de Ronchi D, Fratilionu L, Rucci P, Paternicó A, Graziani S, Dalmonte E. The effect of education on dementia occurrence in an Italian population with middle to high socioeconomic status. Neurology 1998; 50: 1231-8.
76. Boada M, Peña-Casanova J, Bermejo F, Guillén F, Hart WM, Espinosa C, et al. Coste de los recursos sanitarios de los pacientes en régimen ambulatorio diagnosticados de enfermedad de Alzheimer en España. Med Clin (Barc) 1999; 113: 660-95.
77. Abellán A, Fernández-Mayiralas G, Rodríguez V, Rojo F. Envejecer en España. Manual estadístico sobre el envejecimiento de la población. Madrid: Fundación Caja Madrid; 1996.
78. Stern Y, Albert S, Tang MX, Tsai WTT. Rate of memory decline in AD is related to education and occupation. Cognitive reserve? Neurology 1999; 53: 1942-7.
79. Coffey CE, Saxton JA, Rattcliff G, Bryan RN, Lucke JF. Relation of education to brain size in normal aging. Implications for reserve hypothesis. Neurology 1999; 53: 189-96.
80. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 1996; 275: 528-32.
81. Moeri VM, Kukull WA, Emanuel I, van Belle G, Larson EB. Early-life risk factors and the development of Alzheimer's disease. Neurology 2000; 54: 415-20.
82. Sathian K. Practice makes perfect. Sharper tactile perception in the blind. Neurology 2000; 54: 2203-4.
83. Pascual-Leone A, Torres F. Plasticity of the sensorimotor cortex representation of the reading finger in Braille readers. Brain 1993; 116: 39-52.
84. Kipivelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Br Med J 2001; 323: 1447-51.
85. Gwyther LP. Social issues of the Alzheimer's patient and family. Am J Med 1998; 104: S17-21.
86. Hooker K, Manoogian-O'Dell M, Monahan DJ, Frazier LD, Shifrer P. Does type of disease matter? Gender differences among Alzheimer's and Parkinson's disease spouse caregivers. Gerontologist 2000; 40: 568-73.
87. Niki E, Nakano M. Estrogen as antioxidants. Meth Enzymol 1990; 186: 330-3.
88. Behl C, Widman M, Trap T, Holsboer F. 17β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995; 216: 473-82.
89. Gridley KE, Green PS, Simpkins JW. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 1997; 778: 158-65.
90. Luine V. Estradiol increases choline acetyltranferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985; 89: 484-90.
91. Honjo H, Tamura T, Matsumoto Y, et al. Estrogen as a growth factor to central nervous cells. Estrogen treatment promotes development of acetylcholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber. J Steroid Biochem Mol Biol 1992; 41: 633-5.
92. Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990; 10: 1286-91.
93. Wooley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-p-aspartate receptor-dependent mechanism. J Neurosci 1994; 14: 7680-7.
94. Namba H, Solokoff L. Acute administration of high doses of estrogen increases glucose utilization throughout brain. Brain Res 1984; 291: 391-4.
95. Toran-Allerand CD, Miranda RC, Bentham WD, et al. Estrogen receptors co-localize with low-affinity growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A 1992; 89: 4668-72.
96. McEwen BS, Wooley C. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994; 29: 431-6.
97. Srivastava RA, Srivastava N, Averna M, et al. Strogen up-regulate apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J Biol Chem 1997; 27: 33360-6.
98. Schneider LS, Fralow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996; 46: 1580-4.
99. Robinson D, Friedman L, Mracus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994; 42: 919-22.
100. Barret-Connor E, Kirtz-Silverstein D. Estrogen replacement and cognitive function in older. JAMA 1993; 269: 2637-41.
101. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17: 485-95.
102. Jacobs DM, Tang XM, Stern Y, et al. Cognitive function in non-demented older women who took estrogen after menopause. Neurology 1998; 50: 368-73.
103. Drake EB, Henderson VW, Stanczyk FFZ, et al. Associations between circulating sex steroid hormones and cognition in normal elderly woman. Neurology 2000; 54: 599-603.
104. Resnick SM, Metter EJ, Zonderman AB. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology 1997; 49: 1491-7.
105. Schneider LS, Tariot PN. Emerging drugs for Alzheimer's disease. Mechanisms of action and prospects for cognitive enhancing medications. Med Clin N Am 1994; 78: 911-34.
106. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994; 140: 256-61.
107. Kidron D, Black SE, Stanche P, et al. Quantitative MR volumetry in Alzheimer's disease. Topographic markers and effects of sex and education. Neurology 1997; 49: 1504-15.
108. Stern Y, Alexander GE, Prohovnik I, Mayeux R. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 1992; 32: 371-5.